您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Human papillomavirus type 18 E7

Human papillomavirus type 18 E7

货号: S0A2069
价格: 1350
规格: 25μg
介绍: -
其他: -
产品规格
  • 物种

    Human papillomavirus type 18
  • Accession

    P06788
  • 表达序列

    Protein sequence (P06788, Met1-Gln105) MHGPKATLQDIVLHLEPQNEIPVDLLCHEQLSDSEEENDEIDGVNHQHLPARRAEPQRHTMLCMCCKCEARIKLVVESSADDLRAFQQLFLNTLSFVCPWCASQQ

  • 表达宿主

    E.coli
  • 分子量

    Predicted MW: 12.0 kDa Observed MW: 12 kDa
  • 纯度

    >95% by SDS-PAGE
  • 内毒素含量

    <1EU/μg
  • 性状

    Lyophilized Powder
  • 缓冲体系

    Lyophilized from a 0.2 μm filtered solution of 0.2M PBS, pH7.4.
  • 溶解方法

    Reconstitute no more than 1 mg/mL according to the size in deionized water after rapid centrifugation.
  • 储存条件

    12 months from date of receipt, -20 to -70 °C as supplied. 6 months, -20 to -70 °C under sterile conditions after reconstitution. 1 week, 2 to 8 °C under sterile conditions after reconstitution. Please avoid repeated freeze-thaw cycles.

  • 稀释度

背景介绍
  • Human papilloma viruses (HPVs) can be classified as either high-risk or low-risk according to their association with cancer. HPV16 and HPV18 are the most common of the high-risk group while HPV6 and HPV11 are among the low-risk types. Approximately 90% of cervical cancers contain HPV DNA of the high-risk types. Mutational analysis have shown that the E6 and E7 genes of the high-risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high-risk HPV E7 proteins bind to pRB with a higher affinity than do the low-risk HPV proteins. HPV E7 plays a major role in HPV-induced malignancy, perturbing cell cycle regulation, and driving cell proliferation. Major targets of cancer-causing HPV E7 proteins are the pRB family of tumor suppressors, which E7 targets for proteasome-mediated degradation and whose interaction is promoted through an acidic patch, downstream of the LXCXE motif in E7, that is subject to phosphorylation by casein kinase II (CKII).

  • 生物活性JSON

    • Immobilized Human papillomavirus type 18 E7 at 4 μg/mL (50 μL/well) can bind HPV18 E7 Antibody with EC50 of 0.216-0.281 μg/ml.

    • Immobilized Human papillomavirus type 18 E7 at 20 μg/mL (50 μL/well) can bind Human IGFBP3, His tag (S0A3002) with EC50 of 0.185-0.230 μg/ml.

  • 电泳JSON

    • 2 μg(R: reducing conditions)